NYSE American - Nasdaq Real Time Price USD
Kairos Pharma, Ltd. (KAPA)
0.4907
-0.0533
(-9.80%)
At close: June 11 at 3:59:50 PM EDT
0.5059
+0.02
+(3.10%)
After hours: June 11 at 7:59:32 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
5,768
965
1,036
775
Total Liabilities Net Minority Interest
992
3,043
2,215
1,942
Total Equity Gross Minority Interest
4,776
-2,078
-1,179
-1,167
Total Capitalization
4,776
-1,440
-597
-1,167
Common Stock Equity
4,776
-2,078
-1,179
-1,167
Net Tangible Assets
4,554
-2,460
-1,721
-1,869
Working Capital
3,177
-2,304
-1,196
-1,869
Invested Capital
4,776
-1,440
-597
-787
Tangible Book Value
4,554
-2,460
-1,721
-1,869
Total Debt
--
638
582
380
Net Debt
--
545
145
307
Share Issued
13,736.5970
12,841.9370
12,841.9370
12,841.9370
Ordinary Shares Number
13,736.5970
12,841.9370
12,841.9370
12,841.9370
12/31/2021 - 9/16/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABP Abpro Corporation
0.2541
-6.92%
GLYC GlycoMimetics, Inc.
0.1660
-2.58%
SILO Silo Pharma, Inc.
0.5900
+0.51%
REVB Revelation Biosciences, Inc.
0.8309
-1.04%
WINT Windtree Therapeutics, Inc.
0.6998
-12.51%
ELAB PMGC Holdings Inc.
2.1900
+2.34%
ZVSA ZyVersa Therapeutics, Inc.
0.7020
+0.29%
PCSA Processa Pharmaceuticals, Inc.
0.4000
+16.45%
TNFA TNF Pharmaceuticals, Inc.
0.1643
-6.70%
SNPX Synaptogenix, Inc.
5.09
+45.43%